NASDAQ:ICUI - ICU Medical Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $299.30 +1.55 (+0.52 %) (As of 07/17/2018 01:37 PM ET)Previous Close$297.15Today's Range$297.15 - $299.9552-Week Range$164.00 - $313.20Volume1,268 shsAverage Volume220,665 shsMarket Capitalization$6.08 billionP/E Ratio53.94Dividend YieldN/ABeta0.35 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. Receive ICUI News and Ratings via Email Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical SymbolNASDAQ:ICUI CUSIP44930G10 Webwww.icumed.com Phone949-366-2183 Debt Debt-to-Equity RatioN/A Current Ratio4.37 Quick Ratio2.88 Price-To-Earnings Trailing P/E Ratio53.94 Forward P/E Ratio44.94 P/E GrowthN/A Sales & Book Value Annual Sales$1.29 billion Price / Sales4.71 Cash Flow$9.0368 per share Price / Cash33.12 Book Value$59.52 per share Price / Book5.03 Profitability EPS (Most Recent Fiscal Year)$5.52 Net Income$68.64 million Net Margins1.25% Return on Equity9.55% Return on Assets7.47% Miscellaneous Employees6,802 Outstanding Shares20,320,000Market Cap$6,079.86 ICU Medical (NASDAQ:ICUI) Frequently Asked Questions What is ICU Medical's stock symbol? ICU Medical trades on the NASDAQ under the ticker symbol "ICUI." How were ICU Medical's earnings last quarter? ICU Medical, Incorporated (NASDAQ:ICUI) posted its quarterly earnings results on Wednesday, May, 9th. The medical instruments supplier reported $2.26 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.84 by $0.42. The medical instruments supplier earned $372 million during the quarter, compared to the consensus estimate of $346.28 million. ICU Medical had a net margin of 1.25% and a return on equity of 9.55%. The company's revenue was up 50.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.68 earnings per share. View ICU Medical's Earnings History. When is ICU Medical's next earnings date? ICU Medical is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for ICU Medical. What is the consensus analysts' recommendation for ICU Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." Who are some of ICU Medical's key competitors? Some companies that are related to ICU Medical include ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Cantel Medical (CMD), Novocure (NVCR), Merit Medical Systems (MMSI), NuVasive (NUVA), Irhythm Technologies (IRTC) and Nevro (NVRO). Who are ICU Medical's key executives? ICU Medical's management team includes the folowing people: Mr. Vivek Jain, Chairman & CEO (Age 46)Mr. Scott E. Lamb, CFO & Treasurer (Age 55)Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 60)Ms. Alison D. Burcar, Corp. VP of Product Strategy for IV Consumables (Age 45)Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 59) Has ICU Medical been receiving favorable news coverage? Headlines about ICUI stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ICU Medical earned a news sentiment score of 0.13 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 46.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term. Who are ICU Medical's major shareholders? ICU Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.18%), Bank of Montreal Can (0.18%), Clinton Group Inc. (0.06%), Capital One National Association (0.02%), Xact Kapitalforvaltning AB (0.01%) and State of Alaska Department of Revenue (0.01%). Company insiders that own ICU Medical stock include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical. Which institutional investors are selling ICU Medical stock? ICUI stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Scout Investments Inc., Capital One National Association and First Citizens Bank & Trust Co.. Company insiders that have sold ICU Medical company stock in the last year include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain. View Insider Buying and Selling for ICU Medical. Which institutional investors are buying ICU Medical stock? ICUI stock was purchased by a variety of institutional investors in the last quarter, including Clinton Group Inc., State of Alaska Department of Revenue, Campbell & CO Investment Adviser LLC and Xact Kapitalforvaltning AB. View Insider Buying and Selling for ICU Medical. How do I buy shares of ICU Medical? Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ICU Medical's stock price today? One share of ICUI stock can currently be purchased for approximately $299.30. How big of a company is ICU Medical? ICU Medical has a market capitalization of $6.08 billion and generates $1.29 billion in revenue each year. The medical instruments supplier earns $68.64 million in net income (profit) each year or $5.52 on an earnings per share basis. ICU Medical employs 6,802 workers across the globe. How can I contact ICU Medical? ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92673. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected] MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 238 (Vote Outperform)Underperform Votes: 228 (Vote Underperform)Total Votes: 466MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: Are Wall Street analysts' stock ratings worth following?